Demographics and clinical data | |
Total amount of participants | 113 |
Female | 58 (51%) |
Age (years) | 56 [45–67] |
BMI (Kg/m2) | 26.4 ± 4.6 |
NYHA functional class | |
I | 90 (80%) |
II | 15 (13%) |
III | 8 (7%) |
Hypertension | 43 (38%) |
Diabetes mellitus | 5 (4%) |
Dyslipidemia | 27 (24%) |
Smokinga | |
Never | 72 (64%) |
Former | 26 (23%) |
Current | 10 (9%) |
Medications | |
ACE inhibitors or ARBs | 64 (57%) |
Beta-blockers | 41 (36%) |
Spironolactone | 16 (14%) |
Furosemide | 26 (23%) |
Thiazides | 21 (19%) |
Amiodarone | 21 (19%) |
Statins | 23 (20%) |
Aspirin | 21 (19%) |
Electrocardiography | |
1st or 2nd degree AV block | 30 (27%) |
Left bundle branch block | 9 (8%) |
Right bundle branch block | 57 (50%) |
Left anterior fascicular block | 42 (37%) |
Premature ventricular contractions | 17 (15%) |
Low QRS voltage | 13 (12%) |